Location History:
- La Habana, CU (2008)
- Cuidad de la Habana, CU (2013)
Company Filing History:
Years Active: 2008-2013
Title: An Insight into the Innovations of Iraldo Bello Rivero
Introduction
Iraldo Bello Rivero, a notable inventor based in Cuidad de la Habana, Cuba, has made significant contributions to the field of medicine through his innovative pharmaceutical formulations. With a total of two patents, his work primarily focuses on the development of stable treatments that leverage the properties of interferons for addressing complex medical conditions.
Latest Patents
Rivero's latest patents showcase his expertise in creating advanced therapeutic solutions. His first patent is centered around "Stabilized pharmaceutical formulations that contain the interferons gamma and alpha in synergistic proportions." This invention pertains to stable pharmaceutical formulations that can be administered parenterally or topically. These formulations aim to treat both benign and malignant pathological cell growth in tissues and organs, showcasing a promising approach to combat various cancers and other cell growth-related issues.
The second patent, titled "Chimeric antagonist anth1," presents a recombinant chimeric antagonist that merges a 60-amino acid fragment of the N-terminal region of human interleukin 2 (IL-2) with the N-terminal of the extracellular region of the alpha subunit of the gamma IFN receptor. In vitro studies indicate that this protein has T-cell growth-stimulating properties. It also inhibits the growth-stimulating effects of IL-2, the induction of HLA-DR by gamma IFN, and the antiproliferative activity of gamma IFN itself. This invention holds potential for treating a range of disorders, including autoimmune diseases, chronic inflammation, sepsis, and even atherosclerosis.
Career Highlights
Iraldo Bello Rivero is affiliated with the Centro de Ingeniería Genética y Biotecnología, where he continues to research and develop innovative solutions in biotechnology and genetics. His professional journey is characterized by a commitment to enhancing medical treatments through cutting-edge research and application of biotechnological advancements.
Collaborations
Throughout his career, Rivero has collaborated with prominent colleagues including Pedro Lopez Saura and Yanelda Garcia Vega. These collaborations foster a robust environment for creativity and innovation, enabling the development of pioneering solutions that contribute to the state of modern medicine.
Conclusion
Iraldo Bello Rivero stands out as a dedicated inventor in the realm of pharmaceutical innovations. With his two patents focusing on significant medical advancements, he has established himself as a key figure in the field of biotechnology. As he continues his work at the Centro de Ingeniería Genética y Biotecnología, Rivero's contributions hold the promise of transforming therapeutic approaches to challenging health conditions, thereby improving patient outcomes globally.